- $158.83m
- $131.18m
- $13.56m
Hyperfine falls after pricing stock offering
Brief: Hyperfine Announces $6.0 Million Registered Direct Offering
Brief: Hyperfine Terminates About 14% Of Global Workforce
Brief: Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
Hyperfine Inc reports results for the quarter ended September 30 - Earnings Summary
Hyperfine Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Hyperfine Announces European Launch With CE Approval
Hyperfine Inc reports results for the quarter ended in June - Earnings Summary
Hyperfine Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Hyperfine Receives Letter From Nasdaq Staff Indicating It Has Regained Compliance With Bid Price Requirement
Brief: Hyperfine Entered Into A Distribution Agreement With Radiosurgery Global, Ltd. To Develop Market In India
Hyperfine Inc reports results for the quarter ended in March - Earnings Summary
Hyperfine Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Hyperfine Inc To Expand Global Market Reach With Appointment Of International Distributors
Brief: Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
Hyperfine Inc reports results for the quarter ended in December - Earnings Summary
Hyperfine Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Hyperfine Announces Collaboration With Athletic Heart To Provide Brain Health Imaging
Brief: Hyperfine Inc Files For Debt Shelf Of Upto $150 Million - SEC Filing